Evidence map›Paper›PMID 25251243›Full record

ArticlePloS one2014

Deletion of serum amyloid A3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice.

Laura J den Hartigh, Shari Wang, Leela Goodspeed, Yilei Ding, Michelle Averill, Savitha Subramanian, Tomasz Wietecha, Kevin D O'Brien, Alan Chait

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. SAA4: An Underdog Within the Serum Amyloid a Superfamily?International journal of molecular sciences · 2026
    Review
  3. Article
  4. Serum amyloid A in HFpEF and cardiometabolic diseases.Basic research in cardiology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Osteocytes/Osteoblasts Produce SAA3 to Regulate Hepatic Metabolism of Cholesterol.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. A Transcriptomic Response toInternational journal of molecular sciences · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Laura J den HartighDivision of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Shari WangDivision of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Leela GoodspeedDivision of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Yilei DingDivision of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Michelle AverillDivision of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Savitha SubramanianDivision of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Tomasz WietechaDivision of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Kevin D O'BrienDivision of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Alan ChaitDivision of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
University of Washington · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Julie Mathieu · 1986 to 2026
$41.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI ANDREW N HOOFNAGLE · 1986 to 2026
$30.4M
Role of Serum Amyloid A in Diabetic Vascular DiseaseP01HL092969 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 2008 to 2019
$23.5M
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASET32HL007312 · NHLBI · UNIVERSITY OF WASHINGTON · PI MAJESKY, MARK W., SCHWARTZ, STEPHEN MARK · 1985 to 2019
$11.8M
Nutrition, Obesity and Atherosclerosis Training ProgramT32HL007028 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1985 to 2026
$6.4M
Effect of Nutritional Factors on Macrophage Accumulation in Adipose TissueR01HL094352 · NHLBI · UNIVERSITY OF WASHINGTON · PI CHAIT, ALAN · 2009 to 2012
$1.7M
Alterations in Adipocyte Lipid Metabolism by Trans-10, Cis-12 CLA SupplementationK01AT007177 · NCCIH · UNIVERSITY OF WASHINGTON · PI DEN HARTIGH, LAURA JANE · 2013 to 2017
$649k
NCCIH NIH HHS K01 AT007177NCCIH NIH HHS K01 AT007177-01NHLBI NIH HHS P01 HL092969NHLBI NIH HHS R01 HL094352NHLBI NIH HHS T32 HL007028NHLBI NIH HHS T32 HL007312NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK035816
6 · The paper itself

Abstract

Serum amyloid A (SAA) increases in response to acute inflammatory stimuli and is modestly and chronically elevated in obesity. SAA3, an inducible form of SAA, is highly expressed in adipose tissue in obese mice where it promotes monocyte chemotaxis, providing a mechanism for the macrophage accumulation that occurs with adipose tissue expansion in obesity. Humans do not express functional SAA3 protein, but instead express SAA1 and SAA2 in hepatic as well as extrahepatic tissues, making it difficult to distinguish between liver and adipose tissue-specific SAA effects. SAA3 does not circulate in plasma, but may exert local effects that impact systemic inflammation. We tested the hypothesis that SAA3 contributes to chronic systemic inflammation and adipose tissue macrophage accumulation in obesity using mice deficient for Saa3 (Saa3(-/-)). Mice were rendered obese by feeding a pro-inflammatory high fat, high sucrose diet with added cholesterol (HFHSC). Both male and female Saa3(-/-) mice gained less weight on the HFHSC diet compared to Saa3(+/+) littermate controls, with no differences in body composition or resting metabolism. Female Saa3(-/-) mice, but not males, had reduced HFHSC diet-induced adipose tissue inflammation and macrophage content. Both male and female Saa3(-/-) mice had reduced liver Saa1 and Saa2 expression in association with reduced plasma SAA. Additionally, female Saa3(-/-) mice, but not males, showed improved plasma cholesterol, triglycerides, and lipoprotein profiles, with no changes in glucose metabolism. Taken together, these results suggest that the absence of Saa3 attenuates liver-specific SAA (i.e., SAA1/2) secretion into plasma and blunts weight gain induced by an obesogenic diet. Furthermore, adipose tissue-specific inflammation and macrophage accumulation are attenuated in female Saa3(-/-) mice, suggesting a novel sexually dimorphic role for this protein. These results also suggest that Saa3 influences liver-specific SAA1/2 expression, and that SAA3 could play a larger role in the acute phase response than previously thought.

Indexed as

Diet, High-FatAdipose TissueAnimalsDietary SucroseFemaleHyperlipidemiasInflammationLiverMaleMiceMice, Inbred C57BLMice, TransgenicSerum Amyloid A ProteinWeight GainDietary SucroseSaa3 protein, mouseSerum Amyloid A Protein

Identifiers

PMID25251243
PMCPMC4177399
OpenAlexW2090377375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.